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Abstract
Background: Ultrasound (US)-guided fine needle aspiration cytology (FNAC) is an accurate, reliable, and
simple method to identify a thyroid nodule as benign or malignant. However, non-diagnostic cytology results
for thyroid nodules are a major limitation of US-guided FNAC.
Purpose: To investigate the incidence of thyroid cancer among cases with non-diagnostic results on FNAC
and to provide suggestions for the management of thyroid nodules that are initially non-diagnostic by FNAC
according to ultrasonographic findings.
Material and Methods: From July 2006 to December 2009, 10,317 thyroid nodules in 6684 consecutive
patients underwent US-guided FNAC at our institute. Among these, 871 thyroid nodules (8.4%) were
diagnosed as non-diagnostic on initial cytologic evaluation and 196 underwent a second or third FNAC.
Twenty-seven thyroid nodules (18.9%) underwent surgery, while 116 thyroid nodules were cytologically
confirmed as benign with no remarkable change on follow-up US were included. We retrospectively
reviewed the US findings for a total of 143 thyroid nodules (123 benign nodules and 20 malignant nodules).
The US features that we compared included composition, echogenicity, margin, calcifications, shape, and
underlying echogenicity.
Results: In total, thyroid cancer was diagnosed in 20 nodules (14.0%). The size of the nodule was
significantly associated with malignancy (P, 0.05). Most of the sonographically probable benign nodules
were found to be benign (97.6%). Suspicious nodules on US were thyroid cancer in 43.2% of cases. Marked
hypoechogenicity, microlobulated or irregular margin, microcalcifications, and taller-than-wide shape were
significant US findings that correlated with malignancy (P, 0.05). The diagnostic performance of ultrasound
for initially non-diagnostic thyroid nodules was as follows: sensitivity of 90.0%, specificity of 65.0%, positive
predictive value of 29.5%, and negative predictive value of 97.6%.
Conclusion: In terms of management of thyroid nodules with non-diagnostic FNAC cytology, US evaluation
is a feasible and useful method for predicting malignancy.
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Fine needle aspiration cytology (FNAC) of a thyroid nodule
is an accurate, reliable, and minimally-invasive method to
identify a thyroid nodule as benign or malignant. In
addition, the use of ultrasound (US) guidance can improve
diagnostic accuracy by enabling accurate biopsy of a small,
non-palpable thyroid nodule with visualization of the
needle within the lesion. Nowadays, the main role of
FNAC in analyzing thyroid nodules is to triage patients for
either surgery or conservative management with benign,
suspicious, or malignant cytologic evaluation. However, a
dilemma occurs in the 10–21% of patients who have cytolo-
gic ﬁndings that are non-diagnostic, and the current man-
agement of non-diagnostic thyroid nodules remains
controversial (1–4). Repeat aspiration of the thyroid
nodules may help to correct an initial false-negative result,
and Chehade et al. showed a reduction in the false-negative
rate from 5.2% to 1.3% after a second aspiration was per-
formed (5). On the other hand, Shin et al. reported that
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repeat FNAC results are still non-diagnostic in 14% of cases
(6). Previous studies have reported the incidence of malig-
nancy to be 5–37% among non-diagnostic thyroid nodules
(7, 8). Current opinion suggests that non-diagnostic FNACs
should be repeated; however, the algorithm for managing
these non-diagnostic cases has not been established.
The aims of this study were to investigate the incidence of
thyroid cancer among cases with non-diagnostic results on
FNAC and to provide suggestions for the management of
thyroid nodules that are initially non-diagnostic by FNAC
according to ultrasonographic ﬁndings.
Material and Methods
Study sample
This study was approved by our institutional review board.
Informed consent was not required for this retrospective
study; however, informed consent for FNAC had been
obtained from all patients prior to FNAC. From July 2006
to December 2009, 10,317 focal thyroid nodules in 6684 con-
secutive patients underwent US-guided FNAC at our insti-
tution. Among these, 871 thyroid nodules (8.4%) were
diagnosed as non-diagnostic at initial cytologic evaluation,
and 196 thyroid nodules in 190 patients were analyzed by
a second or third FNAC. Second FNAC was performed
for 196/871 nodules with initially non-diagnostic FNAC.
Among them, 60 nodules were performed the third FNAC
due to non-diagnostic results both at ﬁrst and second
FNACs. A repeat FNAC should be more than 90 days
after a previous FNAC to avoid nuclear atypia related to
aspiration (9). Surgery was performed on 27 thyroid
nodules (18.9%, 27 patients), and 116 thyroid nodules
were considered benign and were cytologically conﬁrmed
as benign with no remarkable change on follow-up US. In
the case of benign nodules, patients had to be followed up
for more than 12 months (mean 14.1 months, range 12–36
months). The remaining 53 thyroid nodules were excluded
owing to a lack of ﬁnal cytopathological results such as
surgery or follow-up FNAC. Among them, 11 nodules
were continuously non-diagnostic at ﬁrst, second, and
third FNACs and the remaining 42 nodules were non-
diagnostic at ﬁrst and second FNACs. Finally, 143 thyroid
nodules (27 surgically conﬁrmed thyroid nodules and 116
cytologically conﬁrmed thyroid nodules with no remarkable
change on follow-up US) were included in this study (Fig. 1).
This study included 143 thyroid nodules in 138 patients
(118 women, 20 men). The mean age of the patients was
50.5 years (range 26–79 years), with a mean age of 49.3
years (range 27–67 years) for male patients and a mean
age of 50.7 years (range 26–79 years) for female patients.
The mean lesion size was 10.4 mm (range 3–40 mm).
Fourteen thyroid nodules were palpable and the remaining
129 thyroid nodules (90.2%) were incidentally found on US.
Imaging surveillance
Thyroid US images were obtained using a 7- to 15-MHz
linear array transducer (HDI 5000; Philips Medical
Systems, Bothell, WA, USA), or a 5- to 12-MHz linear array
transducer (iU22; Philips Medical Systems) for the evalu-
ation of thyroid glands and necks. Real-time US was per-
formed by one of three radiologists (two radiologists with
more than 5 years of experience in thyroid US and one radi-
ologist with more than 2 years of experience in thyroid US).
The ultrasonographic ﬁndings of 143 thyroid nodules
were retrospectively reviewed. The length, width, and
depth of each nodule were evaluated on US images and
the size was determined based on the longest aspect. The
location (right and left) of each nodule was also reported.
Focal thyroid nodules were interpreted using US features,
including internal composition (solid, cyst, mixed, sponge
,50%, and sponge .50%), echogenicity (hyper, iso, hypo,
and markedly hypoehcoic), margin (circumscribed, microlo-
bulated, and irregular), combined calciﬁcations (micro,
macro, eggshell, negative, and mixed), shape (parallel and
non-parallel) and underlying echogenicity (homogeneous
and heterogeneous).
Fig. 1 Summary of thyroid nodules characteristics. Stippled lined box represents final inclusion criteria
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Findings on the ﬁnal US assessment were classiﬁed as
probably benign, low suspicious, or suspicious. Malignant
US features were deﬁned as marked hypoechogenicity
(decreased echogenicity compared with the surrounding
strap muscle), microlobulated margin (the presence of
many small lobules on the surface of a nodule), or irregular
margin, microcalciﬁcations, and taller-than-wide shape
(greater in the anteroposterior dimension than the trans-
verse dimension) on the basis of previously published cri-
teria (10). A low suspicious nodule (positive US feature)
was deﬁned if one of the above ﬁndings was present. A sus-
picious nodule was deﬁned as a thyroid nodule with two or
more suspicious features on US. If a nodule showed no sus-
picious features, it was classiﬁed as probably benign.
US-guided FNAC and the reference standard
US-guided FNAC of thyroid nodule was performed by a
radiologist. FNACs were performed for thyroid nodules
with suspicious US features. In patients with more than
one nodule, the most suspicious nodule was aspirated in
accordance with the criteria mentioned above, or the
largest thyroid nodule was aspirated if no suspicious US fea-
tures were detected. US-guided FNAC was performed with
a 23-gauge needle (Korea Vaccine, Seoul, Korea) attached to
a 2-mL disposable syringe (Kovax-Syringe, Seoul, Korea)
without an aspirator. Materials obtained from the aspiration
were expelled onto four glass slides and smeared. All smears
were immediately placed in 95% alcohol for Papanicolau
and hematoxylin and eosin staining. The remainder of the
materials in the syringe was rinsed in saline for processing
as a cell block. Additional special staining was performed
on a case-by-case basis according to the cytopathologists
needs. One of three cytopathologists (over 10 years of experi-
ence) interpreted the FNAC slides.
Specimens were considered non-diagnostic if there was
insufﬁcient cellular material (,6 groups comprised of
.15 well-preserved cells each), if blood was predominantly
present, or if both colloid and follicular cells were present.
Statistical analysis
We compared patients in the benign and malignant groups
according to categorical variables by chi-square test
(nominal data). We also compared continuous variables
between benign and malignant groups by independent two-
sample t-test. Diagnostic performance of US and the inci-
dence of thyroid cancer among the initially non-diagnostic
cases of FNAC were calculated. Statistical signiﬁcance was
assumed when the P value was,0.05. Ninety-ﬁve percent
conﬁdence intervals were calculated for proportions based
on exact binomial tables. Statistical analysis was performed
with SPSS version 15.0 software (SPSS, Chicago, IL, USA).
Results
Patients and final cytopathological results
A total of 143 thyroid nodules from 138 patients were
included in our study. Of these patients, 118 (85.5%) were
female and 20 (14.5%) were male. The mean size of the
thyroid nodule on US was 10.4 mm (range 3–40 mm).
Fourteen thyroid nodules (9.8%) were palpable and the
others were incidentally found on US. Eighty-nine nodules
(62.2%) were located in the right lobe of the thyroid and
54 nodules (37.8%) were located in the left lobe of the
thyroid.
From a total of 143 nodules, thyroid cancer was diag-
nosed by surgery in 20 nodules (14.0%, 19 papillary carci-
nomas and one minimally-invasive Hurthel cell cancer)
and the benign tumors were diagnosed in 123 nodules (7
nodules conﬁrmed by means of surgery and 116 nodules
conﬁrmed by means of repeat FNAC and follow-up US).
The patient demographics are listed in Table 1. Malignant
nodules were signiﬁcantly smaller than benign nodules
(P, 0.05). Differences in age, sex, nodule location, and
symptoms were statistically insigniﬁcant between benign
and malignant nodules.
US analysis
The US features of thyroid nodules are summarized in
Table 2. Sonographically probable benign nodules were
found to be benign in 97.6% of cases. Probably benign,
low suspicious, and suspicious nodules on US were found
to be thyroid cancers in 2.4%, 8.3%, and 43.2% of cases,
respectively (P, 0.05). Marked hypoechogenicity, microlo-
bulated or irregular margin, microcalciﬁcations, and
taller-than-wide shape were signiﬁcant US ﬁndings that cor-
related with malignancy (P, 0.05). The diagnostic perform-
ance of ultrasound for initially non-diagnostic thyroid
nodules was determined to be as follows: sensitivity of
90.0%, speciﬁcity of 65.0%, positive predictive value of
29.5%, and negative predictive value of 97.6%.
Discussion
US-guided FNAC of thyroid nodules is a method used
worldwide to diagnose thyroid nodules. However, FNAC
is limited by non-diagnostic results. Previous studies
report a wide range for the incidence of malignancy in
thyroid nodules with non-diagnostic cytologic results (6–
8, 10). Our study showed non-diagnostic results at initial
FNAC for 8.4% of thyroid nodules, and among these, 14%
Table 1 Comparison of patient demographics by final cytopathol-
ogy for 143 thyroid nodules with initially non-diagnostic FNAC results
Characteristic Malignant Benign P value
Age (years) (mean) 50.7 50.4 0.453
Sex, n (%) 0.275
Men 2 (8.0) 23 (92.0)
Women 18 (15.3) 100 (84.7)
Lesion size (mm) (mean) 8.7 10.7 0.017
Location, n (%) 0.469
Right 13 (14.6) 76 (85.4)
Left 7 (13.0) 47 (87.0)
Symptom, n (%) 0.675
Palpable 1 (7.1) 13 (92.9)
Incidental 19 (14.7) 110 (85.3)
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were ﬁnally conﬁrmed as malignancies. These ﬁndings are
comparable to results from previous reports (range 5–
37%) (6–8, 10). Therefore, determining the cytologic-
clinicoradiologic correlation can be an important follow-up
step for managing thyroid nodules with initially non-
diagnostic cytologic results.
Previous studies have shown that the mean size of benign
thyroid nodules is larger than that for malignant thyroid
nodules, but the difference is not signiﬁcant (10–12). More
recent large-scale studies have shown increasing rates of
small thyroid cancers with advances in diagnostic tech-
niques, such as high-resolution US, and increasing
numbers of imaging studies to establish the diagnostic cri-
teria for thyroid cancer (13–15). In our study, the mean
size of benign thyroid nodules was larger than that for
malignant thyroid nodules, and the size of the lesion was
signiﬁcantly associated with malignancy (8.7 mm for malig-
nant nodules vs. 10.7 mm for benign nodules, P ¼ 0.017).
However, sex, age, location, and symptoms did not differ
between benign and malignant nodules. These results are
probably related to selective thyroid nodules that are
found incidentally on US examination. Increasing numbers
of thyroid nodules are found incidentally on head and
neck ultrasounds for carotid or breast disease and CT or
PET scans for metastatic surveillance (16). The prevalence
of incidental thyroid nodules on US has been found to be
as high as 17–67% (17–19). In our study, 90.2% of thyroid
nodules were found incidentally, which is the highest inci-
dence reported to date.
Many reports have described suspicious US features, such
as microlobulated or irregular margins, hypoechogenicity,
microcalciﬁcations, solid component, a taller-than-wide
shape, and intratumoral vascularity (10, 20–24). In this
study, we used the US classiﬁcation described by Kim
et al. because of its simplicity and high diagnostic accuracy
(10). Our study also shows that the presence of microcalciﬁ-
cations, microlobulated or irregular margins, markedly
hypoechogenicity, and taller-than-wide shape were signiﬁ-
cantly associated with malignancy.
Kwak et al. reported that the rate of malignancy for sono-
graphically suspicious nodules with a non-diagnostic cyto-
logic result was higher than the rate for probably benign
nodules (60.9% vs. 7.7%, respectively) (25). Our study also
showed sonographically suspicious nodules that were
ﬁnally proven to be malignant in 43.2% of cases, and only
2.4% of sonographically probable benign nodules were
malignant in our study. This suggests that suspicious US
features are helpful in the management of thyroid nodules
with initially non-diagnostic cytologic results. For thyroid
nodules with non-diagnostic results by FNAC, a repeat
FNAC should be required because of the high malignancy
rate, which was 14.0% in this study. Repeat FNAC is
needed for thyroid nodules with non-diagnostic results on
initial FNAC, and correlations with US ﬁndings are
helpful for the management of thyroid nodules with non-
diagnostic results after the second or third FNAC.
Previous studies have shown that repeat FNAC is essential
for monitoring thyroid nodules with suspicious US features,
Table 2 Comparison of US features by cytopathology of 143 thyroid nodules that were initially non-diagnostic by FNAC
US feature
Total, n (%) Benign, n (%) Malignant, n (%)
P value(n5 143) (n5 123) (n5 20)
Composition 0.050
Solid 89 (62.2) 71 (79.1) 18 (20.9)
Mixed 41 (28.7) 39 (91.9) 2 (8.1)
,50% sponge 3 (2.1) 3 (2.1) 0 (97.9)
.50% sponge 10 (7.0) 10 ( 7.0) 0 (93.0)
Echogenicity ,0.001
Hyperechoic 3 (2.1) 3 (100) 0 (0)
Isoechoic 36 (25.2) 36 (100) 0 (0)
Hypoechoic 92 (64.3) 79 (85.9) 13 (14.1)
Markedly hypoechoic 12 (8.4) 5 (41.7) 7 (58.3)
Margin ,0.001
Circumscribed 93 (65.0) 89 (95.7) 4 (4.3)
Microlobulated 34 (23.8) 26 (76.5) 8 (23.5)
Irregular 16 (11.2) 8 (50.0) 8 (50.0)
Calcifications ,0.001
Microcalcifications 15 (10.5) 7 (46.7) 8 (53.3)
Macrocalcifications 20 (14.0) 18 (90.0) 2 (10.0)
Eggshell 1 (0.7) 1 (100) 0 (0)
Negative 105 (73.4) 96 (91.4) 9 (8.6)
Mixed 2 (1.4) 1 (50.0) 1 (50.0)
Shape ,0.001
Parallel 106 (74.1) 99 (93.4) 7 (6.6)
Taller-than-wide 37 (25.9) 24 (64.9) 13 (35.1)
Underlying echogenicity 0.69
Homogeneous 135 (94.4) 116 (85.9) 19 (14.1)
Heterogeneous 8 (5.6) 7 (87.5) 1 (12.5)
US assessment ,0.001
Probably benign 82 (57.3) 80 (97.6) 2 (2.4)
Low suspicious 24 (16.8) 22 (91.7) 2 (8.3)
Suspicious 37 (25.9) 21 (56.8) 16 (43.2)
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even when the initial FNAC results are benign or indetermi-
nate (25–27). Follow-up US is required for sonographically
probable benign nodules with non-diagnostic results in
FNAC, and the repeat FNAC is needed when the size or
the US ﬁndings of these nodules has changed on the
follow-up US (Fig. 2).
There were several limitations to our study. First, this
study was a retrospective study where 81% of the lesions
had not been surgically conﬁrmed. There is a possibility
that there were false-positive and false-negative cytological
results. Second, the relatively small sample size (n ¼ 143)
could be a limitation of our study, and a study of a larger
sample is needed to conﬁrm our results. Third, three radiol-
ogists performed US-guided FNAC with interpretations of
US images and thus, there may be inter-observer variability.
US is a very subjective method and is highly dependent on
the skill of the performer. Choi et al. reported that experi-
enced radiologists (more than 6 years of experience in
thyroid imaging) showed more than a moderate degree of
agreement in US assessment of thyroid nodules, and their
ﬁnal assessments were highly accurate (28). However, our
study included one inexperienced radiologist with 2 years
of experience in thyroid imaging. Finally, we excluded 675
non-diagnostic nodules without repeat FNAC. Among
these 675 nodules, 185 nodules had follow-up US without
repeat FNAC, and the remaining 490 nodules had neither
follow-up US nor repeat FNAC. These nodules had
neither cytopathological results nor long-term follow-up of
US; therefore, we excluded large numbers of non-diagnostic
nodules according to our strict inclusion criteria. These non-
diagnostic nodules without repeat FNAC might be new
study materials, and we are checking for these nodules
with long-term follow-up US.
In conclusion, in terms of the management of thyroid
nodules with non-diagnostic FNAC cytology, US evaluation
is a feasible and useful method for predicting malignancy.
Repeat FNAC is essential for non-diagnostic nodules on
initial FNAC, however, follow-up US is a feasible method
for sonographically probable benign nodules that repeat-
edly have non-diagnostic results on FNAC.
Conﬂict of interest: None.
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